Advertisement

Hypertrophische nicht obstruktive Kardiomyopathie (HNCM)

Part of the Handbuch der inneren Medizin book series (INNEREN, volume 9 / 5)

Zusammenfassung

Die hypertrophische nicht obstruktive Kardiomyopathie (HNCM) wird als ätiologisch unklare Hypertrophie der Ventrikelmuskulatur bei normalem oder verkleinertem Ventrikelvolumen und normaler oder erhöhter Austreibungsfraktion sowie fehlender intraventrikulärer Obstruktion im Sinne einer Druckdifferenz definiert. Unter Hypertrophie des Myokards, für die es keine allgemein akzeptierte Definition gibt (Kuhn 1982a,b), wird dabei eine Verbreiterung der Ventri-kelwand bzw. des Ventrikelseptums verstanden. Dabei wird berücksichtigt, daß nach lichtmikroskopischen Kriterien der Durchmesser der Herzmuskelfasern bei HNCM wie bei HOCM völlig normal sein kann (s. Abschn. B).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur zu den Kapiteln HOCM, HNCM und LCM

  1. Abbasi AS, Slaughter JC, Allen MW (1976) Asymmetric septal hypertophy in chronic hemodialysis patients. Circulation 54:11–190Google Scholar
  2. Alday LE, Wagner HR, Vlad P (1972) Severe systemic hypertension and muscular subaor-tic stenosis. Am Heart J 83:395PubMedGoogle Scholar
  3. Anderson DM, Raff GL, Ports TA, Brundage BH, Parmley WW, Chatterjee K (1987) Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic varapamil treatment on left ventricular systolic and diastolic function. Br Heart J 51:523Google Scholar
  4. Balady GJ, Cadigan JB, Ryan TJ (1984) Electrocardiogram of the athlete: An analysis of 289 professional football players. Am J Cardiol 53:1339PubMedGoogle Scholar
  5. Bass CH, Wade C, Hand D, Jackson G (1983) Patients with angina with normal and near normal coronary arteries: Clinical and psychosocial state 12 months after angiography. Br Med J 287:1505Google Scholar
  6. Beahrs MM, Tajik AJ, Seward JB, Giulian ER, McGoon DC (1983) Hypertrophie obstructive cardiomyopathy. Ten-to 21-year follow-up after partial septal myektomy. Am J Cardiol 51:1160PubMedGoogle Scholar
  7. Becker AE, Schoorl R, Balk AG, Heide RM (1975) Cardiac manifestations of Fabry’s disease. Am J Cardiol 36:829PubMedGoogle Scholar
  8. Beckers I, Vandeputte R, Geboers I, Geest H de (1985) HLA complex and hypertrophie cardiomyopathy in an European population. Eur Heart J 6:963PubMedGoogle Scholar
  9. Bemiller CE, Pepine CJ, Rogers AK (1973) Long term observations in patients with angina and normal coronary arteriograms. Circulation 47:36PubMedGoogle Scholar
  10. Berger BC, Abramowitz R, Park CH, Desai AG, Madsen MT, Chung EK, Brest AN (1983) Abnormal Thallium 201 scans in patients with chest pain and angiographically normal coronary arteries. Am J Cardiol 52:365PubMedGoogle Scholar
  11. Betocchi S, Cannon III RO, Watson RM, Bonow RO, Ostrow AG, Epstein SE, Rosing DR (1985) Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophie cardiomyopathy. Circulation 72: 1001PubMedGoogle Scholar
  12. Bienmüller H, Ebner H, Hilpert P (1982) Echokardographische Untersuchungen vor und während des Trainings von Hochleistungssportlern (Skilangläufer). Z Kardiol 71: 754PubMedGoogle Scholar
  13. Bigelow W, Trimble AS, Wigle D, Adelman AG, Felderhof C (1974) The treatment of muscular subaortic stenosis. J Thorac Cardiovasc Surg 68:384PubMedGoogle Scholar
  14. Binet JP, David Ph, Piot JD (1983) Surgical treatment of hypertrophie obstructive car-diomyopathies. Eur Heart J (Suppl F) 4:191Google Scholar
  15. Bircks W, Schulte Hd (1983) Surgical treatment of hypertrophie cardiomyopathy with special reference to complications and to atypical hypertrophie obstructive cardiomyopathy. Heart J (Suppl F) 4:187Google Scholar
  16. Blumenstein M, Burkardt R, Hübner G, Schultheis HP, Strauer BE (1985) Belastungsdys-pnoe bei einem 56jährigen Mann. Internist 26:701PubMedGoogle Scholar
  17. Boden R, Albig M, Barwich D (1978) Kardiale Befunde bei Patienten mit Akromegalie: Eine echokardiographische Studie. Z Kardiol 67:163Google Scholar
  18. Böcker K, Köhler E, Kuhn H, Körfer R (1981) Holosystolischer Mitralklappenprolaps und „SAM“ nach operativer Behandlung einer hypertophisch obstruktiven Kar-diomyopathie. Z Kardiol 70:403PubMedGoogle Scholar
  19. Bonow RO, Rosing DR, Epstein SE (1983 a) The acute and chronic effects of verapamil on left ventricular function in patients with hypertrophie cardiomyopathy. Eur Heart J (Suppl F) 4:57Google Scholar
  20. Bonow RO, Frederick TM, Bacharach SL, Green MV, Goose PW, Maron BJ, Rosing DR (1983b) Atrial systole and left ventricular filling in hypertrophie cardiomyopathy: effect of verapamil. Am J Cardiol 51:1386PubMedGoogle Scholar
  21. Bonow RO, Dilsizian V, Rosing DR, Maron BJ, Bacharach SL, Green MV (1985) Vera-pamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophie cardimyopathy: Short-and long-term effect. Circulation 72:853PubMedGoogle Scholar
  22. Borggrefe M, Kuhn H, Königer HH, Stöter H, Breithardt G, Loogen F, Schulte HD, Bircks W (1983) Arrhythmics in hypertrophic obstructive and non-obstructive car-diomyopathy. Eur Heart J (Suppl F) 4:245Google Scholar
  23. Boudoulas H, Cobb TC, Leighton RF, Wilt SM (1974) Myocardial lactate production in patients with angina-like chest pain and angiographically normal coronary arteries of left ventricle. Am J Cardiol 34:501PubMedGoogle Scholar
  24. Brachfeld N, Gorlin R (1961) Functional subaortic stenosis. Ann Intern Med 54:1Google Scholar
  25. Brandt K, Cathcart E, Cohen A (1968) A clinical analysis of the course and prognosis of fourty-two patients with amyloidosis. Am J Med 44:955PubMedGoogle Scholar
  26. Braunwald E, Aygen M (1963) Idiopathic myocardial hypertrophy without congestive heart failure or obstruction to blood flow. Am J Med 35:7PubMedGoogle Scholar
  27. Braunwald E, Oldham HN, Linhar JW, Mason DT, Fort L (1964) The circulatory response of patients with idiopathic hypertrophic subaortic stenosis to nitroglycerin and to the Valsalva maneuver. Circulation 29:422PubMedGoogle Scholar
  28. Brockenbrough EC, Braunwald E, Morrow AG (1961) A hemodynamic technic for the detection of hypertrophie subaortic stenosis. Circulation 23:189Google Scholar
  29. Brugada P, Bär F, Zwaan C de, Roy D, Green M, Wellens H (1982) Sawfish systolic narrowing of the left anterior descending coronary artery: an angiographie sign of hypertrophie cardiomyopathy. Circulation 66:800PubMedGoogle Scholar
  30. Buchwalsky R (1985) Einschwemmkatheter. perimed, ErlangenGoogle Scholar
  31. Bulkley BH, Hutchins GM (1978) Pompe’s disease presenting as hypertrophie myocardio-pathy with Wolff-Parkinson-White Syndrom. Am Heart J 96:246PubMedGoogle Scholar
  32. Bulkley BH, D’Amico B, Taylor AL (1983) Extensive myocardial fiber disarray in aortic and pulmonary atresia-relevance to hypertrophie cardiomyopathy. Circulation 67:191PubMedGoogle Scholar
  33. Bush CA, Fanning W, Kolibash AJ, Leier CV (1982) Elevated left ventricular filling pressure as a cause of angina in patients with normal coronary arteries. Am J Cardiol 49:950Google Scholar
  34. Canedo IM, Frank M J, Abdulla AM (1980) Rhythm disturbances in hypertrophie cardiomyopathy: Prevalence, relation to symptoms and management. Am J Cardiol 45:848PubMedGoogle Scholar
  35. Cannon RO (1987) Myocardial ischemia in hypertrophie cardiomyopathy. Z Kardiol (Suppl 3) 76:101Google Scholar
  36. Cannon RO, Bonow RO, Bacharach L, Green MV, Rosing DR, Leon MB, Watson RM, Epstein SE (1985 a) Left ventricular disfunction in patients with angina pectoris, normal epicardial coronary arteries and abnormal vasodilator reserve. Circulation 71:218PubMedGoogle Scholar
  37. Cannon RO, Rosing DR, Maron BJ, Leon MB, Bonow RO, Watson RM, Epstein SE (1985b) Myocardial ischemia in patients with hypertrophie cardiomyopathy: Contribution of inadaequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 71:234PubMedGoogle Scholar
  38. Carr D, Friesen HG (1976) Growth hormone and insuline binding to human liver. J Clin Endocrinol Metab 42:484PubMedGoogle Scholar
  39. Chahine RA, Raizner AE, Nelson J, Winters WL, Miller RR, Luchi RJ (1979) Mid systolic closure of aortic valve in hypertrophie cardiomyopathy. Echocardiographic and angiographie correlation. Am J Cardiol 43:17PubMedGoogle Scholar
  40. Chen C, Sakurai, T, Fujta M, Nobuyoshi M, Kawai C (1981) Transient intraventricular conduction disturbances in hypertrophie obstructive cardiomyopathy. Am Heart J 101:672PubMedGoogle Scholar
  41. Ciro E, Maron BJ, Bonow RO, Cannon RO, Epstein SE (1984) Relation between marked changes in left ventricular outflow tract gradient and disease progression in hypertrophic cardiomyopathy. Am J Cardiol 53:1103PubMedGoogle Scholar
  42. Clark CE, Henry WL, Epstein SE (1973) Familial prevalence and genetic transmission of idiopathic hypertrophie subaortic stenosis. N Engl J Med 289:709–714PubMedGoogle Scholar
  43. Cohen A, Hagan AD, Watkins J, Mitas J, Schwartzman M, Mazzoleni A, Cohen IM, Warren SE, Vieweg WV (1981) Clinical correlates in hypertensive patients with left ventricular hypertrophy diagnosed with echocardiography. Am J Cardiol 47:335PubMedGoogle Scholar
  44. Cokkinos DV, Krajcer Z, Leachman RD (1985) Coronary artery diesease in hypertrophic cardiomyopathy. Am J Cardiol 55:1437PubMedGoogle Scholar
  45. Colucci WS, Lorell BH, Schoen FJ, Warhol IM, Grossman W (1982) Hypertrophie obstructive cardiomyopathy due to Fabry’s disease. N Engl J Med 307:926PubMedGoogle Scholar
  46. Cooley DA, Leachman RD, Wukasch DC (1973) Diffuse muscular subaortic stenosis: Surgical treatment, Am J Cardiol 31:1PubMedGoogle Scholar
  47. Cooper M, Shaddy R, Silverman N, Enderlein M (1985) Usefulness of Doppler echocar-diography for determining hemodynamic improvement with introvenous verapamil in hypertrophic cardiomyopathy. Am J Cardiol 56:201PubMedGoogle Scholar
  48. Criley JM, Siegell RJ (1985) Has obstruction hindered our understanding of hypertrophic cardiomyopathy? Circulation 72:1148PubMedGoogle Scholar
  49. Curtius JM, Stechern V, Kuhn H, Loogen F (1984 a) Echokardiographische Verlaufsbeobachtung bei latenter Kardiomyopathie. Z Kardiol 73:695PubMedGoogle Scholar
  50. Curtius JM, Scharf RE, Freund U, Kuhn H (1984 b) Thrombozytenaktivität bei dilatativer und latenter Kardiomyopathie im Vergleich zur koronaren Herzkrankheit. Z Kardiol 73:224PubMedGoogle Scholar
  51. Deeg P, Becker W, Romen W, Haubitz I (1981) Lichtmikroskopische und angiographische Befunde von Patienten mit Angina pectoris und normalen Koronararterien. Z Kardiol 70:629Google Scholar
  52. Desnick RJ, Klionsky B, Sweeley CC (1978) Fabry’s disease (a-galactosidase A deficiency) In: Stanbury JB, Wyngaarden JP, Fredrickson DS (eds) The metabolic basis of inherited disease, 4th edn. Mc Graw-Hill, New York, p 810Google Scholar
  53. Doi YL, Deanfield JE, McKenna WI, Dargie HJ, Oakley CM, Goodwin JF (1980) Echocardiographic differentiation of hypertensive heart disease and hypertrophic cardiomyopathy. Br Heart J 44:395PubMedGoogle Scholar
  54. Doi YL, Hamashige N, Youczawa Y, Ozawa T (1984) Apical hypertrophic cardiomyopathy and ventricular tachycardia. Eur Heart J 5:824PubMedGoogle Scholar
  55. Domenicucci S, Lazzerone E, Roelandt J, Ten Cate FJ, Vletter WB, Arntzenius AC, Das SK (1985) Progression of hypertrophic cardiomyopathy — a cross sectional echocardiographic study. Br Heart J 53:405PubMedGoogle Scholar
  56. Dorp WG van, Ten Cate FJ, Vletter WB, Dohmen H, Roelandt J (1976) Familial prevalence of asymmetric septal hypertrophy. Eur J Cardiol 4:3Google Scholar
  57. Dumesnil JG, Shocr RM (1982) Effect of the geometry of the left ventricle on the calculation of ejection-fraction. Circulation 65-91Google Scholar
  58. Ector H, Bourgois J, Verlinden M, Hermans L, Vanden Eynde E, Fagard R, Geest H de (1984) Bradycardia, ventricular pauses, syncope, and sports. Lancet II:591Google Scholar
  59. Emeriau JP, Fontan F, Besse P, Chauve A, Coqueran JE, Bricaud H (1976) Prognostic value of preoperative left ventricular performance in idiopathic hypertrophic subaortic stenosis. 7th European Congress of Cardiology, AmsterdamGoogle Scholar
  60. Epstein SE, Maron BI (1982) Hypertrophie cardiomyopathy: An overwiev. In: Kaltenbach M, Epstein SE (eds) Hypertrophie cardiomyopathy. Springer, Berlin Heidelberg New York, p 5Google Scholar
  61. Epstein SE, Henry WL, Clark CE, Roberts WC, Maron BI (1974) Asymmetric septal hypertrophy. Ann Intern Med 81:650Google Scholar
  62. Falicov E, Resnekov, L, Bharati S, Lev M (1976) Mid-ventricular obstruction: A variant of obstructive cardiomyopathy. Am J Cardiol 37:432PubMedGoogle Scholar
  63. Farmer D, Hoggins C, Yee E, Lipton M, Wahr D, Ports T (1985) Tissue characterization by magnetic resonance imaging in hypertrophic cardiomyopathy. Am J Cardiol 55:230PubMedGoogle Scholar
  64. Feizi Ö, Farrer-Brown G, Emanuel R (1978) Familial study of hypertrophic cardiomyopathy and congenital aortic valve disease. Am J Cardiol 41:956PubMedGoogle Scholar
  65. Ferrans VJ, Hibbs RG, Burda CD (1969) The heart in Fabry’s disease. A histochemical and electronmicroscopic study. Am J Cardiol 24:95Google Scholar
  66. Ferrans VJ, Morrow AG, Roberts WC (1972) Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. Circulation 45:769PubMedGoogle Scholar
  67. Fester A, Samet P (1974) Passive elasticity of the human left ventricle: the parallel elastic element. Circulation 50:609PubMedGoogle Scholar
  68. Fishbein MC, Blaufuß AH, Zamboni L, Criley JM, Laks MM (1975) Myocardial arterioles in syndrom X. Circulation (Suppl II) 51 and 52:90Google Scholar
  69. Frank MJ, Abdulla FAM, Canedo MI, Saylors RE (1978) Long-term medical management of hypertrophic obstructive cardiomyopathy. Am J Cardiol 42:993PubMedGoogle Scholar
  70. Frank MJ, Abdulla AM, Watkins LO, Prisant L, Stefadouros MA (1983) Long-term medical management of hypertrophic cardiomyopathy: usefulness of propranolol. Eur Heart J (Suppl F) 4:155Google Scholar
  71. Frank MJ, Watkins LO, Prisant LM, Stefadouros MA, Abdulla AM (1984) Potentially lethal arrhythmias and their management in hypertrophic cardiomyopathy. Am J Cardiol 53:1608PubMedGoogle Scholar
  72. Frank S, Braunwald E (1968) Idiopathic hypertrophic subaortic stenosis: Clinical analysis of 126 patients with emphasis on the natural history. Circulation 37:759PubMedGoogle Scholar
  73. Frenzel H, Kuhn H, Hort W (1983) Die diagnostische Bedeutung der Endomyokardbiopsie (EMCB) bei hypertrophischer nicht obstruktiver Kardiomyopathie (HNCM). Z Kar-diol 72:8Google Scholar
  74. Frenzel H, Kasper M, Kuhn H, Lösse B, Reifschneider G, Hort W (1985) Licht-und elektronenmikroskopische Befunde in Früh-und Spätstadien der Herzinsuffizienz. Untersuchungen an Endomyokardbiopsien von Patienten mit latenter (LMC) und dilata-tiver (DCM) Kardiomyopathie. Z Kardiol 74:135PubMedGoogle Scholar
  75. Frenzel H, Schwartzkopff B, Kuhn H, Lösse B, Thormann I, Hort W, Linke R (1986) Cardiac amyloid deposits in endomyocardial biopsies. Am J Clin Pathol 85:674PubMedGoogle Scholar
  76. Fritz P, Schneider H, Heimburg P, Wegner G (1978) Sekundäre hypertrophe obstruktive Kardiomyopathie bei Morbus Fabry. Med Welt 29:1851PubMedGoogle Scholar
  77. Froelicher VF, Yanowitz FG, Thompson AJ, Lancaster MC (1973) The correlation of coronary angiography and the electrocardiographic response to maximal treadmill testing in 76 asymptomatic men. Circulation 48:597PubMedGoogle Scholar
  78. Gach IV, Andriange M, Frank G (1971) Hypertrophie obstructive cardiomyopathy and Friedreichs ataxia. Am J Cardiol 27:436PubMedGoogle Scholar
  79. Gardin JM, Talano JV, Stepanides L, Fizzano J, Lesch M (1981) Systolic anterior motion on the absence of asymmetric septal hypertrophy. A buckling phenomenon of the chordae tendineae. Circulation 63:181PubMedGoogle Scholar
  80. Gardin JM, Dabestani A, Glasgow GA, Butman S, Burn CS, Henry WL (1985) Echocar-diographic and Doppler flow observations in obstructed and non obstructed hyper-trophic cardiomyopathy. Am J Cardiol 56:614PubMedGoogle Scholar
  81. Gerbaux A, Hanania G, Godefroid A, Barajan J, Maoudad I, Gay I (1976) Résultats à long terme du traitement chirurgical de la myocardiopathie obstructive par intervention sur le septum interventriculaire. Arch Mal Coeur 69:791PubMedGoogle Scholar
  82. Gertz EW, Wisneski JA, Neese R, Houser A, Korte R, Bristow JD (1980) Myocardial lactate extraction: Multidetermined metabolic function. Circulation 61:256PubMedGoogle Scholar
  83. Gietzen F, Blümm R, Frenzel H, Kuhn H (1985) Diagnose der hypertrophischen Kar-diomyopathien mittels Kardiocomputertomographie. Z Kardiol (Suppl 3) 74:63Google Scholar
  84. Gleichmann U, Ohlmeier H, Trieb G, Nannebach H (1981) Exercise induced angina pec-toris due to abnormal left ventricular compliance. Acta Med Scand (Suppl) 644:23Google Scholar
  85. Goodwin JF (1970) Congestive und hypertrophic cardiomyopathies. Lancet II:731Google Scholar
  86. Goodwin JF (1974) IHSS.HOCM. ASH. A plea for unity. Am Heart J 89:269Google Scholar
  87. Goodwin JF, Oakley CM (1972) The cardiomyopathies. Br Heart J 34:545PubMedGoogle Scholar
  88. Haasis R, Jeschke D (1972) Ursachen des akuten Herztodes beim Jugendlichen. Verh Dtsch Ges lnn Med 78:1048Google Scholar
  89. Hager W, Wilhelms W, Hierholzer E, Brass R, Dohmen K, Kuwert E (1979) Zur Frage der Immungenese der obstruktiven Kardiomyopathien. Z Kardiol 68:527PubMedGoogle Scholar
  90. Hamada M, Matsubara W, Tomita N, Miyauchi Y, Kokubu T (1985) Left atrial mobile thrombus in hypertrophic cardiomyopathy. Am J Cardiol 56:812PubMedGoogle Scholar
  91. Hanrath P, Schweitzer P, Bleifeld W, Essen R von, Effert S (1977) Familiäre asymmetrische Septumhypertrophic mit und ohne Obstruktion. Dtsch Med Wochenschr 102:751PubMedGoogle Scholar
  92. Hanrath P, Schlüter M, Sonntag F, Diemert G, Bleifeld W (1983) Influence of verapamil therapy on left ventricular performance at rest and during exercise in hypertrophic cardiomyopathy. Am J Cardiol 52:544PubMedGoogle Scholar
  93. Harmjanz D, Böttcher D, Schertlein (1971) Correlations of electrocardiographic pattern, shape of ventricular septum and isovolumetric relaxation time in irregular hypertrophic cardiomyopathy. Br Heart J 23:928Google Scholar
  94. Hassenstein P, Storch HH, Schmitz W (1975) Erfahrungen mit der Schrittmacherdauerbehandlung bei Patienten mit obstruktiver Kardiomyopathie. Thoraxchirurgie 23:496Google Scholar
  95. Hearne MI, Sherber HS, Leon AC de (1975) Asymmetric septal hypertrophy in acromegaly. An echocardiographic study. Circulation (Suppl II) 52:35Google Scholar
  96. Henry WL, Chester EC, Epstein SE (1973) Asymmetric septal hypertrophy: The unifying link in the IHSS disease spectrum: Observation regarding its pathogenesis, pathophy-siology and course. Cirlculation 47:827Google Scholar
  97. Henry L, Clark CE, Griffith JM, Epstein SE (1975) Mechanism of left ventricular outflow obstruction in patients with obstructive asymmetric septal hypertrophy (IHSS). Am J Cardiol 35:337PubMedGoogle Scholar
  98. Herman MV, Cohn PF, Golin R (1973) Angina-like chest pain without identifiable cause. Ann Intern Med 79:445PubMedGoogle Scholar
  99. Hess OM, Göbel NH, Luescher H, Schneider J, Angehrn W, Krayenbühl HP (1979) Left ventricular function in patients with hypertrophic nonobstructive cardiomyopathy. Eur J Cardiol 9:129PubMedGoogle Scholar
  100. Hess OM, Schneider J, Turina M, Dieth K, Krayenbühl HP (1982) Asymmetric septal hypertrophy in patients with aortic stenosis: An adaptive mechanism or a co-existence of hypertrophic cardiomyopathy? Am J Cardiol 49:923Google Scholar
  101. Hess OM, Grimm J, Krayenbühl HP (1983) Diastolic function in hypertrophic cardiomyopathy: effects of propranolol and verapamil on diastolic stiffness. Eur Heart J (Suppl 4) 4:47PubMedGoogle Scholar
  102. Higgins CM, Byrd BF, Stark D, McNamary M, Lanzer P, Lipton M, Botvinick E, Chat-terjee K (1985) Magnetic resonance imaging in hypertrophic cardiomyopathy. Am J Cardiol 55:1121PubMedGoogle Scholar
  103. Hirota Y, Furubayashi K, Kaku K, Shinizu G, Kino M, Kawamura K, Takatsu T (1982) Hypertrophie non obstructive cardiomyopathy: a precise assessment of hemodynamic characteristics and clinical implications. Am J Cardiol 50:990PubMedGoogle Scholar
  104. Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT (1981) Release of prostaglandines and thromboxane into the coronary circulation in patients with is-chemic heart disease. N Engl J Med 304:685PubMedGoogle Scholar
  105. Hopf R, Kaltenbach M (1982) Die hypertrophische Kardiomyopathie. Möglichkeiten der kalciumantagonistischen Behandlung. Thieme, Stuttgart New YorkGoogle Scholar
  106. Isner JM, Cherke RH, Pandian NG, Donaldson DN, Konstam MA, Payne DD, Cleveland RJ (1984) Laser myoplasty for hypertrophic cardiomyopathy. Am J Cardiol 53:1620PubMedGoogle Scholar
  107. Jackson G, Richardson PJ, Atkinson L, Armstrong P, Oram S (1978) Angina with normal coronary arteriograms, value of coronary sinus lactate estimation in diagnosis and treatment. Br Heart J 40:976PubMedGoogle Scholar
  108. Jansen A (1988) Angina pectoris und normales Koronarangiogramm. Untersuchungen zum Krankheitsbild der latenten Kardiomyopathie (LCM). Promotionsschrift, Universität DüsseldorfGoogle Scholar
  109. Janson R, Lackner K, Grube E, Thurn P (1979) Nicht invasive Diagnostik der idiopathi-schen hypertrophischen subvalvulären Aortenstenose (IHSS) mit der Computertomographie (CT) (Abstr.). Z Kardiol 68:270Google Scholar
  110. Jenni R, Ruffmann K, Vieli, A, Anliker M, Krayenbühl HP (1985) Dynamics of aortic flow in hypertrophic cardiomyopathy. Eur Heart J 6:391PubMedGoogle Scholar
  111. Johnson AD, Lonky SA, Carleton RA (1975) Combined hypertrophic subaortic stenosis and calcific aortic valvular stenosis. Am J Cardiol 35:709Google Scholar
  112. Johnson RE, Williams BR, Liberman HA, Morris DC, Logue RB (1981) Stress Thallium szintigraphy in patients with left bundle branch block. Circulation (Suppl IV) 64: 105Google Scholar
  113. Jones M, Barnhardt GR, Morrow AG (1982) Late results after operations for left ventricular outflowtract obstruction. Am J Cardiol 50:569PubMedGoogle Scholar
  114. Juillet Y, Grosgogeat Y (1971) L’amyloidose cardiaque: Aspects cliniques, radiologiques, electriques, hemodynamiques, evolutifs et anatomiques. Arch Mal Coeur 4:361Google Scholar
  115. Jung K, Schäfter-Nolte W (1982) Todesfälle in Zusammenhang mit Sport. Dtsch Z Sport Med 1:5Google Scholar
  116. Kaltenbach M, Hopf R, Kober G, Bussmann WD, Keller M, Petersen Y (1979) Treatment of hypertrophic obstructive cardiomyopathy with verapamil. Br Heart J 42:35PubMedGoogle Scholar
  117. Kawai C, Sakurai T, Fujiwara H, Matsumori A, Yui Y (1983 a) Hypertrophic obstructive and non obstructive cardiomyopathy in Japan. Diagnosis of the disease with special reference to endomyocardial catheter biopsy. Eur Heart J (Suppl F) 4:121Google Scholar
  118. Kawai C, Yui Y, Hoshino T, Sasayama S, Matsumori A (1983 b) Myocardial cate-cholamines in hypertrophic and dilated (congestive) cardiomyopathy: a biopsy study. J Am Coll Cardiol 2:834PubMedGoogle Scholar
  119. Kemp HG, Vokonas S, Cohn PF, Gorlin R (1973) The anginal syndrom associated with normal coronary arteriograms. Am J Med 54:735PubMedGoogle Scholar
  120. Keren G, Belhassen B, Sherez J, Miller HI, Megidish R, Berenfeld D, Laniado S (1985) Apical hypertrophic cardiomyopathy: Evaluation by non invasive and invasive techniques in 23 patients. Circulation 71:45PubMedGoogle Scholar
  121. Kishel JC, Chavez AM, Baron CJ, Roberts WC (1982) Infective endocarditis in hyper-trophic cardiomyopathy: Analysis of 5 patients requiring mitral valve replacement. Am J Cardiol 49:949Google Scholar
  122. Knieriem HJ, Stroobandt R, Meyer H, Bourgeois M (1975) Hypertrophie non obstructive cardiomyopathy caused by disorder of the myofiber texture. Virchow Arch [A] 367:209Google Scholar
  123. Kobayashi K, Tarazi RC, Lovenberg W, Rakusan K (1984) Coronary blood flow in genetic cardiac hypertrophy. Am J Cardiol 53:1360PubMedGoogle Scholar
  124. Kober G, Schmidt-Moritz A, Hopf R, Kaltenbach M (1983) Long-term treatment of hypertrophic obstructive cardiomyopathy — usefulness of verapamil. Eur Heart J (Suppl F) 4:165Google Scholar
  125. Kober G, Hopf R, Miamino G, Bubenheimer P, Förster K, Kuck KH, Hanrath P, Olshausen KE, Schlepper M, Kaltenbach M (1987) Long-term treatment of hyper-trophic cardiomyopathy with verapamil or propranolol in matched pairs of patients: results of a multicenter study. Z Kardiol (Suppl 3) 76:113PubMedGoogle Scholar
  126. Koch JP, Maron BJ, Epstein SE, Morrow AG (1980) Results of operation for obstructive hypertrophic cardiomyopathy in the elderly. Am J Cardiol 46:963PubMedGoogle Scholar
  127. Köhler E, Thurow J, Kuhn H, Neuhaus Ch, Bluschke V, Bosilj M (1979) Klinische und echokardiographische Untersuchungen zur familiären Verbreitung der hypertrophisch obstruktiven (HOCM) und hypertrophisch nicht obstruktiven (HNCM) Kardiomyo-pathie. Z Kardiol 68:511PubMedGoogle Scholar
  128. Köhler E, Böcker K, Leuner CH, Jungblut R, Schoppe W, Nessler L, Minami K, Loogen F (1981) Die diagnostische Wertigkeit von M-mode, zweidimensionalem Echokardiogramm und Computertomographie im Vergleich zur Herzkatheteruntersuchung bei der Erkennnung kardialer Tumoren. Z Kardiol 70:571PubMedGoogle Scholar
  129. Körfer R, Bausch H, Kuhn H, Schulte HD, Bircks W (1983) Hypertrophisch obstruktive Kardiomyopathie (HOCM). Z Allg Med 59:634Google Scholar
  130. Koga Y, Itaya K, Toshima H (1984) Prognosis in hypertrophic cardiomyopathy. Am Heart J 108:315Google Scholar
  131. Kostis JB, Moreyra AE, Natarajan N, Hosler M, Kuo PT, Conn HL (1979) Pathophysiol-ogy and diverse etiology of septal perforator compression. Circulation 59:913PubMedGoogle Scholar
  132. Kowey PR, Eisenberg R, Engel TR (1984) Sustained arrhythmias in hypertrophic obstructive cardiomyopathy. N Engl J Med 310:1566PubMedGoogle Scholar
  133. Krasnow N, Stein RA (1978) Hypertrophie cardiomyopathy in the aged. Am Heart J 96:326PubMedGoogle Scholar
  134. Krasnow N, Stein R, Liebermann A, Shanta N, Summers DN, Nacht R (1981) Hypertrophic cardiomyopathy in old age: A comparison of severity and natural history with younger patients. Circulation (Suppl IV) 64:26Google Scholar
  135. Krelhaus W, Kuhn H, Loogen F (1978) Analysis of deaths in the course of hypertrophic obstructive cardiomyopathy. In: Kaltenbach M, Loogen F, Olsen EGJ (eds) Cardiomyopathy and myocardial biopsy. Springer, Berlin Heidelberg New York, p 300Google Scholar
  136. Kreulen TH, Gorlin R, Herman MV (1973) Ventriculographic patterns and hemodynamics in primary myocardial disease. Circulation 47:299PubMedGoogle Scholar
  137. Kruck I, Andreas S, Berhöfer G, Schröder R, Biamino G (1987) Dopplerechokardio-graphische Befunde bei hypertropher Kardiomyopathie. Herz 12:226PubMedGoogle Scholar
  138. Krüger SK, French JW, Forker AD, Caudill CC, Popp RL (1979) Echocardiography in discrete subaortic stenosis. Circulation 59:506Google Scholar
  139. Kuck KH, Hanrath, P, Kunze KP, Dernedde, J, Geiger M, Bleifeld W (1984) Elektro-physiologische Untersuchungen bei Patienten mit hypertropher Kardiomyopathie — Erkennung von Risikopatienten für den plötzlichen Herztod? Z Kardiol 73:43Google Scholar
  140. Kuck KH, Kunze KP, Schlüter M, Nienaber CA, Costard A (1988) Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope. Eur Heart J 9:177PubMedGoogle Scholar
  141. Kuhn H (1980) Die latente Kardiomyopathie (LCM). Intern Welt 10:373Google Scholar
  142. Kuhn H (1981) Invasive Diagnostik bei Kardiomyopathien. Verh Dtsch Ges Herz Kreislaufforsch 47:217PubMedGoogle Scholar
  143. Kuhn H (1982a) Left ventricular hypertrophy in clinical practice: cardiomyopathies. Eur Heart J 3:287Google Scholar
  144. Kuhn H (1982b) The definition of ventricular hypertrophy. Eur Heart J (Suppl A) 3:5Google Scholar
  145. Kuhn H (1982c) Treatment of hypertrophic cardiomyopathies, Synopsis. In: Epstein SE, Kaltenbach (eds) Verapamil treatment of hypertrophic cardiomyopathy. Springer, Berlin Heidelberg New York, p 160Google Scholar
  146. Kuhn H (1985 a) Myokardhypertrophic: Rückbildung bei hypertrophischen Kardiomyopathien? Z Kardiol (Suppl 7) 74:179PubMedGoogle Scholar
  147. Kuhn H (1985 b) Evidence for the importance of obstruction in hypertrophic cardiomyopathy. In: Goodwin JF (ed) Heart muscle disease. MTP Press, Lancester, p 213Google Scholar
  148. Kuhn H (1985 c) Kardiovaskuläre Erkrankungen und Nervensystem. Verh Dtsch Ges Neurol 5:20Google Scholar
  149. Kuhn H, Loogen F (1978) Die Anwendung von Betarezeptorenblockern bei hypertrophischer obstruktiver Kardiomyopathie (HOCM). Internist 10:527Google Scholar
  150. Kuhn H, Loogen F (1981a) Latente Kardiomyopathie. In: Krayenbühl P, Kübier W (Hrsg) Kardiologie in Klinik und Praxis. Thieme, Stuttgart New York, S 38Google Scholar
  151. Kuhn H, Loogen F (1981 b) Die Erkrankungen des Myokards. In: Krayenbühl HP, Kübier W (Hrsg) Kardiologie in Klinik und Praxis. Thieme, Stuttgart New York, S 48Google Scholar
  152. Kuhn H, Breithardt G, Knieriem HJ, Scipel L, Loogen F (1975) Linksschenkelblock bei congestiver Kardiomyopathie. Z Kardiol (Suppl II) 64:30Google Scholar
  153. Kuhn H, Haensch R, Jehle J (1977) Hypertrophisch obstruktive Kardiomyopathie und Lentiginosis. Dtsch Med Wochenschr 102:679PubMedGoogle Scholar
  154. Kuhn H, Breithardt G, Knieriem HJ, Köhler E, Lösse B, Scipel L, Loogen F (1978 a) Prognosis and possible presymptomatic manifestations of congestive cardiomyopathy. Postgrad Med J 54:451PubMedGoogle Scholar
  155. Kuhn H, Breithardt G, Knieriem HJ, Loogen F (1978 b) Endomyocardial catheter biopsy in heart disease of unknown etiology. In: Kaltenbach M, Loogen F, Olsen EGJ (eds) Cardiomyopathy and myocardial biopsy. Springer, Berlin Heidelberg New York, p 121Google Scholar
  156. Kuhn H, Krelhaus W, Bircks W, Schulte HD, Loogen F (1978 c) Indication for surgical treatment in patients with hypertrophic obstructive cardiomyopathy. In: Kaltenbach M, Loogen F, Olsen EGJ (eds) Cardiomyopathy and myocardial biopsy. Springer, Berlin Heidelberg New York, p 308Google Scholar
  157. Kuhn H, Köhler E, Krelhaus W, Bircks W, Loogen F (1978 d) Die hypertrophischen Kardiomyopathien. Diagnostische und therapeutische Möglichkeiten. Therapiewoche 28:9956Google Scholar
  158. Kuhn H, Lösse B, Hort W, Loogen F (1979) Studies for the early detection of congestive cardiomyopathy in patients with left bundle branch block. Circulation (Suppl II) 59 and 60:37Google Scholar
  159. Kuhn H, Knieriem HJ, Breithardt G, Hort W, Loogen F (1980 a) Diagnostic aspects of endomyocardial catheter biopsy. — clinical and electromicroscopic correlations. In: Bolte HD (ed) Myocardial biopsy — diagnostic significance. Springer, Berlin Heidelberg New York, p 22.Google Scholar
  160. Kuhn H, Lösse B, Hort W (1980 b) Studies in patients with abnormal electrocardiogram of unknown etiology. In: Kübier W, Tillmanns H, Zebe H (eds) Microcirculation of the heart, theoretical and clinical problems. Springer, Berlin Heidelberg New York, p 288Google Scholar
  161. Kuhn H, Thelen U, Köhler E, Lösse B (1980 c) Die hypertrophische nicht obstruktive Kardiomyopathie (HNCM) — klinische, hämodynamische, elektro-echo-und angio-kardiographische Untersuchungen. Z Kardiol 69:457PubMedGoogle Scholar
  162. Kuhn H, Lösse B, Boch H, Becker R, Hort W (1981) Prognosis of patients with congestive cardiomyopathy (CCM) — therapeutic, hemodynamic, morphologic and metabolic aspects. In: Goodwin JF, Hjalmarson A, Olsen EGF (eds) Congestive cardiomyopathy. Hässle, Mölndal (Sweden), p 213Google Scholar
  163. Kuhn H, Becker R, Fischer J, Curtius JM, Lösse B, Loogen F (1982 a) Untersuchungen zur Ätiologie, zum Verlauf und zur Prognose der dilatativen Kardiomyopathie (DCM) Z Kardiol 71:497PubMedGoogle Scholar
  164. Kuhn H, Köhler E, Hort W, Frenzel H (1982 b) Concealed myocardial storage disease (Fabry’s disease): Pitfalls in the diagnosis of hypertrophic non obstructive cardiomyopathy. Circulation (Suppl II) 66:117Google Scholar
  165. Kuhn H, Mercier J, Köhler E, Frenzel H, Hort W, Loogen F (1983 a) Differential diagnosis of hypertrophic cardiomyopathies: typical (subaortic) hypertrophic obstructive cardiomyopathy, atypical (midventricular) hypertrophic obstructive cardiomyopathy and hypertrophic non-obstructice cardiomyopathy. Eur Heart J (Suppl F) 4:93Google Scholar
  166. Kuhn H, Gietzen F, Mercier J, Lösse B, Köhler E, Schulte HD, Bircks W, Loogen F (1983 b) Untersuchungen zur Klinik, zum Verlauf und zur Prognose verschiedener Formen der hypertrophischen Kardiomyopathie. Z Kardiol 72:83PubMedGoogle Scholar
  167. Kuhn H, Gietzen F, Blümm R, Waßmuth E, Pfeiffer K (1985) Klinische Bedeutung der Kardiocomputertomographie bei Kardiomyopathien. Z Kardiol (Suppl 5) 74:107Google Scholar
  168. Kuhn H, Jansen A, Steeger M, Lösse B, Kladetzky R, Frenzel H (1986) Angina pectoris und normales Koronarangiogramm, Untersuchungen zum Krankheitsbild der latenten Kardiomyopathie (LCM). Z Kardiol 75 (Suppl 1) 1:41Google Scholar
  169. Kuhn H, Blümm R, Gietzen F, Böcker K, Waßmuth E (1987) Diagnosis of hypertrophic cardiomyopathies by non-ECG-gated cardiac computed tomography (CCT). Z Kardiol (Suppl 3) 76:53Google Scholar
  170. Kunkel B, Kober G, Lapp H, Leuschner U, Kaltenbach M (1977) Klinische, licht-und elektronenmikroskopische Befunde bei frühen und fortgeschrittenen Formen conge-stiver Kardiomyopathien. Z Kardiol 66:198PubMedGoogle Scholar
  171. Kunkel B, Schneider M, Kober G, Kaltenbach M (1984) Bioptische Befunde bei Patienten mit normalen Kranzarterien. Herz Kreislauf 9:451Google Scholar
  172. Landmark K, Sire S, Thanlow E, Pamlie I, Nitter-Hauge S (1982) Hemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy. Br Heart J 48:19PubMedGoogle Scholar
  173. Laslett LJ (1984) Management of the asymptomatic patients with an abnormal exercise ECG. JAMA 252:1744PubMedGoogle Scholar
  174. Letac B, Berland J, Cribier A, Cazor JL (1981) Clinical, electrocardiographic, hemodynamic and metabolic data in patients with angina like chest paint. Circulation (Suppl IV) 64:305Google Scholar
  175. Lippe A von der, Storstein L, Akre S (1981) Double blind intravenous trial of Verapamil and placebo in angina pectoris without obstructive coronary artery disease. Eur Heart J (Suppl A) 2:55Google Scholar
  176. Lösse B, Kuhn H (1982) Belastungsuntersuchungen bei Patienten mit Kardiomyopathie. Herz 7:91PubMedGoogle Scholar
  177. Lösse B, Kuhn H, Krönert H, Rafflenbeul D, Köhler E, Schicha H, Feinendegen LE (1979) Hämodynamische und radiokardiographische Belastungsuntersuchungen bei Patienten mit komplettem Linksschenkelblock und normal großem Herzen. Z Kardiol 68:304PubMedGoogle Scholar
  178. Lösse B, Kuhn H, Rafflenbeul D, Krönert H, Hort W, Feinendegen LE, Loogen F (1980a) Thallium 201 Myokardszintigraphie bei Patienten mit normalen Koronararterien und normalem Ventriculogramm — Vergleich mit hämodynamischen, metabolischen und morphologischen Befunden. Z Kardiol 69:523PubMedGoogle Scholar
  179. Lösse B, Kuhn H, Krönert H, Rafflenbeul D, Kirschner P, Schulte HD, Loogen F (1980 b) Hämodynamische Auswirkungen konservativer und operativer Therapie bei hypertrophischer obstruktiver Kardiomyopathie. Z Kardiol 69:466Google Scholar
  180. Lösse B, Kuhn H, Loogen F, Schulte HD (1983) Exercise performance in hypertrophic cardiomyopathies. Eur Heart J (Suppl F) 4:197Google Scholar
  181. Lösse B, Heinold F, Curtius JM, Loogen F (1985) Klinische und hömodynamische Früh-und Langzeiteffekte von Verapamil bei hypertrophischer obstruktiver Kardiomyo-pathie (HOCM). Z Kardiol (Suppl 5) 74:52Google Scholar
  182. Lohe E van der, Müller-Haake C, Minale C, Essen R von, Effert S, Messemer BJ (1984) Septumresektion bei hypertropher obstruktiver Kardiomyopathie. Dtsch Med Wochenschr 109:1749PubMedGoogle Scholar
  183. Loogen F, Kuhn H (1977) Classification and natural history of primary cardiomyopathy. In: Riecker G, Weber A, Goodwin J (eds) Myocardial failure. Springer, Berlin Heidelberg New York, p 232Google Scholar
  184. Loogen F, Gleichmann U, Krelhaus W (1971) Die obstruktive Myokardiopathie. Z Kardiol 60:1044Google Scholar
  185. Loogen F, Kuhn H, Neuhaus L (1976) Störungen der Ventrikelfunktion bei Kardiomyo-pathien. Verh Dtsch Ges Herz Kreislaufforsch 42:63Google Scholar
  186. Loogen F, Kuhn H, Krelhaus W (1978) Natural history of hypertrophic obstructive cardiomyopathy and the effect of therapy. In: Kaltenbach M, Loogen F, Olsen EGJ (eds) Cardiomyopathy and myocardial biopsy. Springer, Berlin Heidelberg New York, p 286Google Scholar
  187. Loogen F, Kuhn H, Gietzen F, Lösse B, Schulte HD, Bircks W (1983) Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and with hypertrophic non obstructive cardiomyopathy. Eur Heart J (Suppl F) 4:145Google Scholar
  188. Lorell BH, Paulus WG, Grossmann W, Wynne J, Cohn PF (1982) Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy. Circulation 65:499PubMedGoogle Scholar
  189. MacAlpin RN, Abbasi AS (1973) Human coronary artery size during life. A cinearterio-graphic study. Diagn Radiol 108:567Google Scholar
  190. Mall G (1988) Kardiomyopathien aus der Sicht des Pathologen. Therapiewoche (im Druck)Google Scholar
  191. Mammohansingh P, Parker JO (1975) Angina pectoris with normal coronary arteri-ograms: Hemodynamic and metabolic response to atrial pacing. Am Heart J 90:555PubMedGoogle Scholar
  192. Maron BJ (1983) Echocardiographic assessment of left ventricular hypertrophy in patients with obstructive or non-obstructive hypertrophic cardiomyopathy. Eur Heart J (Suppl F) 4:73Google Scholar
  193. Maron BJ (1985) Asymmetry in hypertrophic cardiomyopathy: The septal to free wall thickness ratio revisited. Am J Cardiol 55:835PubMedGoogle Scholar
  194. Maron BJ, Roberts WC (1979) Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 59:689PubMedGoogle Scholar
  195. Maron BJ, Ferrans VJ, Henry WL, Clark CE, Redwood DR, Roberts WC, Morrow AG, Epstein SE (1974) Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH): Light-and electronmicroscopic findings. Circulation 50:436PubMedGoogle Scholar
  196. Maron BJ, Savage DD, Clark CE, Henry WL, Vlodaver Z, Edwards JE, Epstein SE (1978 a) Prevalence and characteristics of disproportionate ventricular septal thickening in patients with coronary artery disease. Circulation 57:250PubMedGoogle Scholar
  197. Maron BJ, Verter J, Kapur S (1978 b) Disproportionate ventricular septal thickening in the developing normal human heart. Circulation 57:520PubMedGoogle Scholar
  198. Maron BJ, Roberts WC, Edwards JE, MacAllister HA, Foley DD, Epstein SE (1978 c) Sudden death in patients with hypertrophic cardiomyopathy: Characterization of 26 patients without functional limitation. Am J Cardiol 41:803PubMedGoogle Scholar
  199. Maron BJ, Merrill WH, Freier PA, Kent KM, Epstein SE, Morrow AG (1978 d) Long term chinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis. Circulation 57:1205PubMedGoogle Scholar
  200. Maron BJ, Epstein SE, Roberts WC (1979 a) Hypertrophie cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Circulation 43:1086Google Scholar
  201. Maron BJ, Sato N, Roberts WC, Edwards JE, Chandra RS (1979 b) Quantitative analysis of cardial muscle cell disorganization in the ventricular septum. Comparison of fetuses and infants with and without congenital heart disease and patients with hypertrophic cardiomyopathy. Circulation 60:685PubMedGoogle Scholar
  202. Maron BJ, Savage DD, Wolfson J, Epstein SE (1981) Prognostic significance of 24-hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy. Am J Cardiol 48:252PubMedGoogle Scholar
  203. Maron BJ, Tajik AS, Ruttenberg HD, Graham TP, Atwood GF, Victorica BE, Lie JT, Roberts WC (1982 a) Hypertrophie cardiomyopathy in infants: clinical features and natural history. Circulation 65:7PubMedGoogle Scholar
  204. Maron BJ, Roberts WC, Epstein SE (1982 b) Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation 65:1388PubMedGoogle Scholar
  205. Maron BJ, Epstein SE, Roberts WC (1983) Hypertrophie cardiomyopathy: a common cause of sudden death in the young competitive athlete. Eur Heart J (Suppl F) 4:135Google Scholar
  206. Maron BJ, Nichols PF, Pickle LW, Weseley YE, Mulvihill JJ (1984 a) Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol 53:1087PubMedGoogle Scholar
  207. Maron BJ, Epstein SE, Bonow RO, Wyngearden MK, Wesley YE (1984 b) Obstructive hypertrophic cardiomyopathy associated with minimal left ventricle hypertrophy. Am J Cardiol 53:377PubMedGoogle Scholar
  208. Maron BJ, Wolfson IK, Epstein SE, Roberts WC (1987) Morphologic evidence for “small vessel disease” in patients with hypertrophic cardiomyopathy. Z Kardiol (Suppl 3) 76:91PubMedGoogle Scholar
  209. Martin RP, Rakowski H, French J, Popp R (1979) Idiopathic hypertrophic subaortic stenosis viewed by wide-angle, phased-array echocardiography. Circulation 59:1206PubMedGoogle Scholar
  210. Martins J, Kerber R, Sherman B, Marcus M, Erhardt R (1977) Cardiac size and function in acromegaly. Circulation 56:863PubMedGoogle Scholar
  211. Matsumori A, Kawai C, Wakabayashi A, Terasaki PT, Prk MS, Sakurami T, Keno Y (1981) HLA-DRW 4 antigen linkage in patients with hypertrophic obstructive cardiomyopathy. Am Heart J 101:14PubMedGoogle Scholar
  212. McKenna WJ (1983) Arrhythmia and prognosis in hypertrophic cardiomyopathy. Eur Heart J (Suppl F) 4:225Google Scholar
  213. McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J (1981) Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 47:532PubMedGoogle Scholar
  214. Meesen H, Poche R (1967) Beiträge zur pathologischen Anatomie der Fallotschen Fehler und zur idiopathischen Herzhypertrophic. Anglo-German Med Rev 4:73Google Scholar
  215. Menapace FI, Hammer WJ, Kessler KK, Ritzer T, Bove AA, Warner HH, Span JF (1977) Echocardiographic measurements of left ventricular wall thickness in weight lifters: A problem with the definition of ASH. Am J Cardiol 39:276Google Scholar
  216. Mintz GS, Korler MN, Segal BL, Parry WR (1978) Systolic anterior motion of the mitral valve in the absence of asymmetric septal hypertrophy. Circulation 57:256PubMedGoogle Scholar
  217. Mirski J, Cohn PF, Levinde JA, Gorlin R, Herman MV, Kreulen TH, Sonnenblick EH (1974) Assessment of left ventricular stiffness in primary myocardial disease and coronary artery disease. Circulation 50:128Google Scholar
  218. Morgera T, Salvi A, Alberti E, Silvestri F, Cammerini F (1985) Morphological findings in apparently idiopathic ventricular tachycardia. An echocardiographic, hemodynamic and histologie study. Eur Heart J 6:323PubMedGoogle Scholar
  219. Morrow AG, Reitz BA, Epstein SE, Henry WL, Conkle DM, Itscoitz SB, Redwood DR (1975) Operative treatment in hypertrophic subaortic stenosis. Circulation 52:88PubMedGoogle Scholar
  220. Morrow AG, Koch JP, Maron BJ, Kent KM, Epstein SE (1980) Left ventricular myotomy and myectomy in patients with obstructive hypertrophic cardiomyopathy and previous cardiac arrest. Am J Cardiol 46:313PubMedGoogle Scholar
  221. Müller S, Müller P, Volkmann H, Meyer R, Pocher K, Zinner G (1984) Thallium 201 imaging in correlation to right ventricular biopsy findings and hemodynamic parameters in patients with latent forms of cardiomyopathy. Eur Heart J (Abstract (Suppl I) 5:65Google Scholar
  222. Munscheck H (1976) Der plötzliche Tod beim Sport infolge Myokarditis. Sportarzt Sportmed 9:201Google Scholar
  223. Murgo JP, Miller JW (1985) Hemodynamic, angiographic and echocardiographic evidence against impeded ejection in hypertrophic cardiomyopathy. In: Goodwin JF (ed) Heart muscle disease. MTP Press, New York, p 187Google Scholar
  224. Murgo JP, Alter BR, Dorethy JF, Altobelli SA, McGraham GM (1980) Dynamics of left ventricular ejection in obstructive and non obstructive hypertrophic cardiomyopathy. J Clin Invest 66:1369PubMedGoogle Scholar
  225. Murgo JP, Alter BR, Dorethy JF, Altobelli SA, Craig WE, McGraham GM (1983) The effects of intraventricular gradients on left ventricular ejection dynamics. Eur Heart J (Suppl F) 4:23Google Scholar
  226. Nicolosi GL, Pavan D, Lestuzzi C, Burelli C, Zardo F, Zanuttini D (1984) Prospective identification of patients with amyloid heart disease by two-dimensional echocardio-graphy. Circulation 70:432PubMedGoogle Scholar
  227. Nimura Y, Nagata S, Sakakibara, H, Beppu S, Park YD, Kinoshita N, Miyatake K (1980) Newer aspects in hypertrophic cardiomyopathy, studied with cross-sectional echcardio-graphy. In: uSekiguchi M, Olsen EGJ (eds) Cardiomyopathy, clinical, pathological and theoretical aspects. University Park Press, Baltimore, p 13Google Scholar
  228. Oakley CM (1972) Clinical definitions and classification of cardiomyopathies. Postgrad Med J 48:703PubMedGoogle Scholar
  229. Oakley DG, Oakley CM (1982) Significance of abnormal electrocardiograms in highly trained athlets. Am J Cardiol 50:985PubMedGoogle Scholar
  230. Olsen EGJ (1972) Pathology of primary cardiomyopathies. Postgrad Med J 48:732PubMedGoogle Scholar
  231. Olsen EGJ (1983) Anatomic and light-microscopic characterization of hypertrophic obstructive and non-obstructive cardiomyopathy. Eur Heart J (Suppl F) 4:1Google Scholar
  232. Opherk D, Zebe H, Weihe E, Mall G, Durr C, Graven B, Mehmel HC, Schwarz F, Kübier W (1981a) Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary angiograms. Circulation 63:817PubMedGoogle Scholar
  233. Opherk D, Zebe H, Weihe E, Mall G, Maurer W, Gravert B, Mehmel HC, Schuler G, Kübier W (1981b) Das Syndrom peetanginöser Beschwerden bei Patienten mit normalem Koronarogramm (Syndrom X). Dtsch Med Wochenschr 106:1686PubMedGoogle Scholar
  234. Perrot B, Dandin N, Chaise AT de la (1984) Verapamil: A cause of sudden death in a patient with hypertrophic cardiomyopathy. Br Heart J 51:352PubMedGoogle Scholar
  235. Polani PE, Moynahan EJ (1972) Progressive cardiomyopathic lentiginosis. Q J Med 42:205Google Scholar
  236. Pollick C (1982) Muscular subaortic stenosis. Hemodynamic and clinical improvement after disopyramide. N Engl J Med 307:997PubMedGoogle Scholar
  237. Pollick C, Morgan CD, Gilbert BW, Rakowski H, Wigle ED (1982) Muscular subaortic stenosis: The temporal relationship between systolic anterior motion of the anterior mitral leaflet and the pressure gradient. Circulation 66:1087PubMedGoogle Scholar
  238. Rahlf G (1984) Die intramyokardiale Mikroarteriopathie und das Syndrom X. Herz Kreislauf 9: 441Google Scholar
  239. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies (1980). Br Heart J 44:672Google Scholar
  240. Roberts WC (1973) Valvular, subvalvular and supravalvular aortic stenosis: Morphologic features. Cardiovasc Clin 5:104Google Scholar
  241. Roberts WC, Ferrans VJ (1973) Morphologic observations in the cardiomyopathy. In: Fowler NO (ed) Myokardial disease. Grune & Stratton, New YorkGoogle Scholar
  242. Rosing DR, Kent KM, Borer JS, Scides SF, Maron BJ, Epstein SE (1979) Verapamil Therapy: A new approach to the pharmacologie treatment of hypertrophic cardiomyopathy. I. Circulation 60:1201PubMedGoogle Scholar
  243. Rosing DR, Condit JR, Maron BJ, Kent KM, Leon MB, Bonow RO, Lipson LC, Epstein SE (1981) Verapamil therapy: A new approach to the pharmacologie treatment of hypertrophic cardiomyopathy: III. Effects of long-term, administration. Am J Cardiol 48:545PubMedGoogle Scholar
  244. Rosing DR, Idänpäan-Heikkilä U, Maron BJ, Bonow RO, Epstein SE (1985) Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy. Am J Cardiol 55:185BPubMedGoogle Scholar
  245. Rossen RM, Goodman DJ, Ingham RE, Popp RL (1974) Echocardiographic criteria in the diagnosis of idiopathic hypertrophic subaortic Stenosis. Circulation 50:747PubMedGoogle Scholar
  246. Rothlin ME, Gobet D, Haberer T, Krayenbühl HP, Turina M, Senning A (1983) Surgical treatment versus medical treatment in hypertrophic obstructive cardiomyopathy. Eur Heart J(Suppl F) 4:215Google Scholar
  247. Ruser HR (1982) Morbus Friedreich als neurokardiologische Krankheit. Herz Kreislauf 10:558Google Scholar
  248. Ruskin JN, McGovern B, Garan H, DiMarco JP, Kelly E (1983) Antiarrhythmic drugs: A possible cause of out-of hospital cardiac arrest. N Engl J Med 309:1302PubMedGoogle Scholar
  249. Sajkiewicz K, Meyer R, Becker H, Schröder G (1983) Demonstration seltener Erkrankungen des Myokards bei klinischer Fragestellung Kardiomyopathie. Symposium Kar-diomyopathien, Abstract Nr. 55, p 52, JenaGoogle Scholar
  250. Savage DD, Scides SF, Maron BJ, Myers DJ, Epstein SE (1979) Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and non-obstructive hypertrophic cardiomyopathy. Circulation 59:866PubMedGoogle Scholar
  251. Schapira JM, Stemple DR, Martin RP, Rakowski H, Stinson EB, Popp RL (1978) Single and two dimensional echocardiographic visualization of the effects of septal myectomy in idiopathic hypertrophic subaortic stenosis. Circulation 58:850PubMedGoogle Scholar
  252. Schmitz H, Krüger K, Walther B, Schattenkirchner M, Oxenham R, Parker K (1981) Hypertrophe nicht obstruktive Kardiomyopathie bei Hämochromatose. Z Kardiol 70:347Google Scholar
  253. Schneider JF, Emerson TH, Kreger BE, McNamara PM, Kännel WB (1978) Newly acquired left bundle branch block: the Framingham Study. Ann Intern Med 90:303Google Scholar
  254. Schneider R, Köhler D, Berghöfer G, Paeprer H, Felix R, Thormann J, Schörner W, Schmutzler H (1985) Nachweis der regionalen Hypertrophie bei hypertrophischer Kardiomyopathie mit der EKG-getriggerten Kernspintomographie — Vergleich mit Hypertonikern und Herzgesunden. Z Kardiol 74:144PubMedGoogle Scholar
  255. Schuler G, Opherk D, Schwarz F, Görlich I, Manthey I (1986) Prognostic significance of concomitant left bundle branch block in patients with reduced coronary dilatory capacity with syndrome X. Circulation (Suppl II) 449Google Scholar
  256. Schulte HD, Bircks W, Körfer R, Kuhn H (1981) Surgical aspects of typical subaortic and atypical midventricular hypertrophic obstructive cardiomyopathy (HOCM). Thorac Cardiovasc Surg 475:380Google Scholar
  257. Sedlis SP, Saffritz JE, Schwob VS, Jaffe AS (1984) Cardiac amyloidosis simulating hyper-trophic cardiomyopathy. Am J Cardiol 53:679Google Scholar
  258. Sekiguchi M, Hasumi M, Hiroe M, Kasanuki H, Ohnishi S, Hirosawa K (1985) On the existence of non hypertrophic, non dilated cardiomyopathy as assessed by endomyocar-dial biopsy and a proposal for the term “electric disturbance type of cardiomyopathy”. Circulation (Suppl III) 72:156Google Scholar
  259. Sévère GR, Donnowan T, Grodzinski E, Blümchen G (1986) Verlaufsbeobachtungen (4,6 Jahre) bei Patienten mit latenter Kardiomyopathie. Z Kardiol 75:496PubMedGoogle Scholar
  260. Shah M, Adelman AG, Wigle ED, Gobel FL, Burchel HB (1974) The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy. Circ Res (Suppl II) 34 + 35:179Google Scholar
  261. Shapiro LM, Kleinebenne A, McKenna WI (1985) The distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: Comparison to athletes and hypertensives. Eur Heart J 6:967PubMedGoogle Scholar
  262. Sheikhzadeh A, Stierle U, Diederich KW (1985) Nicht invasive und invasive Untersuchungsverfahren bei hypertrophischer Kardiomyopathie. Herz 10:59PubMedGoogle Scholar
  263. Sheth KJ, Thomas JP (1982) Electrocardiograms in Fabry’s disease. J Electrocardiol 15:153PubMedGoogle Scholar
  264. Shub C, Williamson MD, Tajik AJ, Eubanks DR (1981) Dynamik left ventricular outflow tract obstruction associated with pheochromocytoma. Am Heart J 102:286PubMedGoogle Scholar
  265. Simon AL (1972) Angiographie appearance of idiopathic hypertrophic subaortic stenosis. Circulation 46:614PubMedGoogle Scholar
  266. Smith ER, Heffermenn LP, Saugalang VE, Vaughan LM, Flemington CS (1976) Voluntary muscle involvement in hypertrophic cardiomyopathy. Ann Intern Med 85:566PubMedGoogle Scholar
  267. Sowton E (1976) Betarezeptorenblocker bei hypertropher Kardiomyopathie. In: Schweizer W (Hrsg) Die Betabiocker, Gegenwart und Zukunft. Huber, Bern, S 239Google Scholar
  268. Speiser KW, Krayenbühl HP (1981) Reappraisal of the effect of acute betablockade on left ventricular filling dynamics in hypertrophic obstructive cardiomyopathy. Eur Heart J 2:21PubMedGoogle Scholar
  269. Spicer RL, Rocchini AP, Crowley IC, Rosenthal A (1984) Chronic verapamil therapy in pediatric and young adult patients with hypertrophic cardiomyopathy. Am J Cardiol 53:1614PubMedGoogle Scholar
  270. Spiller P, Brenner C, Karsch KR, Loogen F, Neuhaus KL (1977) Systolische und diastoli-sche Funktion des linken Ventrikels bei hypertropischer obstruktiver Kardiomyopathie. Z Kardiol 66:483PubMedGoogle Scholar
  271. Spirito P, Maron BJ, Rosing DR (1984) Morphologie determinants of hemodynamic state after ventricular septal myotomy — myectomy in patients with obstructive hypertrophic cardiomyopathy: M-Mode and two-dimensional echocardiographic assessment. Circulation 70:984PubMedGoogle Scholar
  272. Stierle U, Sheikhzadeh A, Diederich KW, Langbehn AF, Fröschlin R (1985) Linksven-trikuläre Ejektionsdynamik bei apikaler Hypertrophie, einer Form der hypertrophischen nicht obstruktiven Kardiomyopathie. Herz 10:72PubMedGoogle Scholar
  273. Storstein L, Abrahamsen AM, Storstein O (1981) Hemodynamic effects of strophanthin and pindolol in patients with hypertrophic cardiomyopathy. Eur Heart J 2:297PubMedGoogle Scholar
  274. Strauer BE (1975) Die hypertrophisch obstruktive Kardiomyopathie. Internist 16:530PubMedGoogle Scholar
  275. Strauer BE, Mahmoud, Bayer F, Bohn I, Motz U (1984) Reversal of left ventricular hypertrophy and improvement of cardiac function in man by nifedipine. Eur Heart J (Suppl 5) 5:53PubMedGoogle Scholar
  276. Sutton MGStJ, Tajik AJ, Giuliani ER, Gordon H, Suw PD (1981) Hypertrophie obstructive cardiomyopathy and lentiginosis a little known neural ectodermal syndrom. Am J Cardiol 47:214Google Scholar
  277. Sutton MG, Reichek N, Kastor JA, Giuliani ER (1982) Computerized M-mode echocardiographic analysis of left ventricular disfunction in cardiac amyloid. Circulation 66:790Google Scholar
  278. Suzuki Y, Kadota K, Nohara R, Tamaki S, Kambara H, Yoshida A, Murakami T, Osakada G, Kawai C, Tamaki N, Mukai T, Torizuka K (1984) Recognition of regional hypertrophy in hypertrophic cardiomyopathy using Thallium-201 emission-computed tomography: Comparison with two dimensional echocardiography. Am J Cardiol 53:1095PubMedGoogle Scholar
  279. Tauchert N, Behrenbeck DW, Hoetzel J, Hombach V, Jansen W, Niehus B, Obst HP, Hilger HH (1978) Funktioneller Nachweis der small vessel disease. Verh Dtsch Ges Herz Kreislaufforsch 44:172Google Scholar
  280. ten Cate FJ, Roelandt J (1979) Progression of left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy. Am Heart J 97:762PubMedGoogle Scholar
  281. ten Cate FJ, Serruys PW, Mey S, Roelandt J (1983) Effects of short term administration of verapamil of left ventricular relaxation and filling dynamics measured by a combined hemodynamic-ultrasonic technique in patients with hypertrophic cardiomyopathy. Circulation 68:1274Google Scholar
  282. Thaulow E, Eriksson J, Nitter-Hauge S, Rootwelt K (1980) False positive exercise test — a sign of cardiomyopathy? Eur Congr Kardiol Paris, Abstract Book p 127Google Scholar
  283. Thelen M (1982) Kardiocomputertomographie bei Kardiomyopathien. Dtsch Med Wo-chenschr 107:1859Google Scholar
  284. Tilley LP, Liu SK, Gilbertson SR, Wagner BM, Lord PF (1977) Primary myocardial disease in the cat. Am J Pathol 86:493PubMedGoogle Scholar
  285. Tilmant PY, Lablanche JM, Laurent JM, Hethuin JP, Folliot JP, Bertrand ME (1980) Myocardiopathie hypertrophique apicale non obstructive. Arch Mal Coeur 73:1269PubMedGoogle Scholar
  286. Topol EJ, Traill TA, Fortuin NJ (1985) Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 312:277PubMedGoogle Scholar
  287. Trieb G, Sigwart H, Mannebach H, Gleichmann U (1979) Segmentale frühzeitige Relaxation (SERP) des linken Ventrikels in Ruhe vs. ischämieinduzierter Hypokinesie im Belastungsangiogramm — eine Korrelationsstudie. Z Kardiol 68:520PubMedGoogle Scholar
  288. Turcot J, Laurencean JL, Dumesnil JG (1977) Echocardiographic findings in Olympic athletes (Abstr). Proceedings of the 30th annual meeting of the Canadian Cardiovascular Society, Toronto, Oct 19-22, p 40Google Scholar
  289. Uhl GS, Kay NT, Hickman JR (1981) Computer enhanced Thallium scintigrams in asymptomatic men with abnormal exercise tests. Am J Kardiol 48:1037Google Scholar
  290. Vasey C, O’Donnell J, Morris S, McHenry P (1985) Exercise induced left bundle branch block and its relation to coronary artery disease. Am J Kardiol 56:892Google Scholar
  291. Vecht RJ, Oakley CM (1968) Infective endocarditis in three patients with hypertrophic obstructive cardiomyopathy. Br Med J 2:455PubMedGoogle Scholar
  292. Velebit V, Podrid PJ, Lown B, Cohen BH, Graboys TB (1982) Aggravation of ventricular arrhythmia by antiarrhythmic drugs. Circulation 65:886PubMedGoogle Scholar
  293. Vogel M, Freedom RM, Brand A, Trusler GA, Williams WG, Rowe RD (1983) Ventricular septal defect and subaortic stenosis: An analysis of 41 patients. Am J Cardiol 52:1258PubMedGoogle Scholar
  294. Warnes CA, Maron BJ, Roberts WC (1984) Massive cardiac ventricular scarring in first degree relatives with hypertrophic cardiomyopathy. Am J Cardiol 54:1377PubMedGoogle Scholar
  295. Wellens HJ, Bär FW, Vanagt EJ, Brugada P (1982) Medical treatment of ventricular tachycardia: considerations in the selection of patients for surgical treatment. Am J Cardiol 49:190Google Scholar
  296. White CW, Zimmermann TJ (1975) Prolonged left ventricular ejection time in the post premature beat: A sensitive sign of idiopathic hypertrophic subaortic stenosis. Circulation 52:306PubMedGoogle Scholar
  297. Wigle ED, Silver MD (1978) Myocardial fibre disarray and ventricular septal hypertrophy in asymmetrical hypertrophy of the heart. Circulation 58:398PubMedGoogle Scholar
  298. Wigle ED, Adelman AG, Anger P, Marquis Y (1969) Mitral regurgitation in muscular subaortic stenosis. Am J Cardiol 24:698PubMedGoogle Scholar
  299. Wigle ED, Adelman AG, Felderhof CH (1974) Medical and surgical treatment of the cardiomyopathies. Circ Res (Suppl II) 34 + 35:196Google Scholar
  300. Wigle ED, Henderson M, Pollick C, Sasson Z, Rakowski H (1985) Muscular subaortic stenosis (hypertrophic obstructive cardiomyopathy) the evidence for obstruction to left ventricular outflow. In: JF Goodwin (ed) Heart muscle disease. MTP Press, Lancester, p 217Google Scholar
  301. Wizemann V, Kramer W, Kindler M, Thormann I (1986) Kardiale Befunde bei chronischen Dialysepatienten. Klinikarzt 15:318Google Scholar
  302. Yamaguchi H, Ischimura T, Nishiyama S, Nagasaki F, Nakanishi S, Takatsu F, Nishija T, Umeda T, Machii K (1979) Hypertrophie non-obstructive cardiomyopathy with giant negative T waves (apical hypertrophy): Ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 44:401PubMedGoogle Scholar
  303. Yamaguchi H, Nishijama S, Nakanishi S, Nishimura S (1983) Elektrocardiographic, echocardiographic and ventriculographic characterization of hypertrophic non obstructive cardiomyopathy. Eur Heart J (Suppl F) 4:105Google Scholar
  304. Zeppilli P, Pirrami MM, Sassara M, Fenici R (1980) T-wave abnormalities in top-ranking athletes: Effects of isoproterenol, atropine, and physical exercise. Am Heart J 100:213PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • H. Kuhn

There are no affiliations available

Personalised recommendations